A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes, according to a study published this week in the journal Angewandte Chemie.
Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, in collaboration with GBDbio, a Texas A&M spinoff company, and investigators at Stanford University, have identified a new chemical compound to spot the bacteria that cause TB with a level of sensitivity that currently takes months to produce; and results of the first human clinical trial data are promising. Findings show the test can determine that a patient has tuberculosis with 86 percent sensitivity and 73 percent specificity. Smear microscopy, the most widely used test in the world, has a significantly lower ability to detect TB, ranging between 50 to 60 percent sensitivity.
Although preventable, TB claims three lives every minute, making it the second leading cause of mortality from an infectious disease in the world. Spread through the air when an individual with active TB infection coughs or sneezes, reports show that if left untreated, a person with active TB infects an average of 10 to 15 people each year, leaving a great need for faster, more reliable testing.
Cirillo’s latest breakthrough perfects the technology behind the test. Using a fluorescent substrate, the device targets BlaC – an enzyme produced by the bacteria that cause TB – as an indicator of the bacteria’s presence. Until now, it has not been possible to target a specific TB enzyme for diagnosis.
Read more . . .
The Latest on: Tuberculosis
[google_news title=”” keyword=”Tuberculosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tuberculosis
- Shortage Of TB Medicines: Patients Rely On Double Dose Of Paediatric Medicines To Fight Tuberculosison May 7, 2024 at 2:15 pm
Acute shortage of regular medicines has forced more than 2,700 patients in Indore to turn to paediatric medicines’ double dose to fight tuberculosis.The scarcity is already two months old with no solution in sight.
- California Declares Public Health Emergency Amid Tuberculosis Outbreakon May 7, 2024 at 1:16 pm
The purpose of the declaration is not to cause panic but to prepare the city to respond to any localized Tuberculosis outbreak. According to a statement by the city's government, it will be considered for ratification by the city council on Tuesday ...
- GSK expands collaboration with BioVersys on tuberculosis asset alpibectiron May 7, 2024 at 11:08 am
GSK (NYSE:GSK) will expand its collaboration with BioVersys AG on the development of tuberculosis candidate alpibectir as well as take an equity stake in the Swiss biopharma's latest round. BioVersys said the GSK investment of CHF 12.
- Hidden Figures Of Healthcare: Meet The Black Nurses Who Helped Cure Tuberculosison May 7, 2024 at 8:15 am
Until recently, the stories of these Black nurses went largely untold. The book "Black Angels" shares how they helped save countless lives despite discrimination.
via Bing News